Observational study evaluate pathology practice use artificial intelligence in patient suspected lung and breast cancer - CASCADE

Study identifier:D4191R00089

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

A non-interventional study evaluating samples from patients with suspected non-small lung cancer or breast cancer to describe pathology practices and to evaluate computational pathology plus artificial intelligence algorithms.

Medical condition

lung cancer

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

600

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 15 Mar 2025
Estimated Primary Completion Date: 31 May 2027
Estimated Study Completion Date: 31 May 2027

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2025 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria